RESPIGAM
RESPIGAM
Discontinued
DIN Number
02232479
Drug Class
Human
Market Date
N/A
Company
HC
MedImmune LLC
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02232479
AIG Number0132654002
Classification & Schedule
C
Drug Class
Human
S
Schedule
Schedule D
A
ATC Code
J06BA02 IMMUNOGLOBULINS, NORMAL HUMAN, FOR INTRAVASC. ADM.
Product Specifications
Dosage FormPowder For Solution
Route of AdministrationIntravenous
AHFS Classification80:04.00
Health Canada Classification
ACTIVE INGREDIENTS (1)
RESPIRATORY SYNCYTIAL VIRUS IMMUNE GLOBULIN INTRAVENOUS (HUMAN)Active
Strength: 2500 MG / VIAL
Monograph: RESPIRATORY SYNCYTIAL VIRUS IMMUNE GLOBULIN INTRAVENOUS (HUMAN)